We are live on ! Find out more
CGL

Clarius Group LLC Portfolio holdings

AUM $1.75B
1-Year Est. Return 19.04%
This Fund
S&P 500
This Quarter Est. Return
+10.44%
1 Year Est. Return
+19.04%
3 Year Est. Return
+92.07%
5 Year Est. Return
+98.79%
10 Year Est. Return
+415.93%
AUM
$1.29B
AUM Growth
+$116M
Cap. Flow
+$6.02M
Cap. Flow %
0.46%
Top 10 Hldgs %
52.74%
Holding
529
New
19
Increased
248
Reduced
179
Closed
39

Sector Composition

Rank Sector Weight
1 Technology 18.57%
2 Industrials 17.79%
3 Consumer Discretionary 8.08%
4 Healthcare 7.99%
5 Financials 5.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PCAR icon
1
PACCAR
PCAR
$69.9B
$192M 14.87%
2,299,842
-64,924
-3% -$4.8M
MSFT icon
2
Microsoft
MSFT
$2.86T
$114M 8.8%
334,418
-1,624
-0.5% -$509K
AMZN icon
3
Amazon
AMZN
$2.5T
$61M 4.71%
467,556
-2,173
-0.5% -$248K
OMFL icon
4
Invesco Russell 1000 Dynamic Multifactor ETF
OMFL
$4.69B
$56.5M 4.36%
1,152,640
-11,257
-1% -$534K
FNDA icon
5
Schwab Fundamental US Small Company Index ETF
FNDA
$9.18B
$55M 4.25%
2,181,522
+24,820
+1% +$596K
VOO icon
6
Vanguard S&P 500 ETF
VOO
$968B
$51.3M 3.96%
125,865
+879
+0.7% +$339K
IEMG icon
7
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
$47M 3.63%
952,773
+28,424
+3% +$1.39M
IDEV icon
8
iShares Core MSCI International Developed Markets ETF
IDEV
$31B
$44M 3.4%
719,902
+5,835
+0.8% +$358K
AAPL icon
9
Apple
AAPL
$4.89T
$37.8M 2.92%
194,952
-3,647
-2% -$635K
SPY icon
10
State Street SPDR S&P 500 ETF Trust
SPY
$777B
$23.6M 1.82%
53,224
+16
+0% +$6.71K
KRTX
11
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$21.5M 1.66%
99,221
-20,475
-17% -$4.39M
RODM icon
12
Hartford Multifactor Developed Markets ex-US ETF
RODM
$1.58B
$19.6M 1.51%
743,653
+4,093
+0.6% +$109K
NVDA icon
13
NVIDIA
NVDA
$5T
$15.5M 1.2%
367,480
+11,980
+3% +$398K
FNDC icon
14
Schwab Fundamental International Small Company Index ETF
FNDC
$3.01B
$14.1M 1.09%
424,711
+529
+0.1% +$17.7K
ECML icon
15
Euclidean Fundamental Value ETF
ECML
$128M
$14M 1.08%
+507,159
New +$13.2M
TSLA icon
16
Tesla
TSLA
$1.22T
$12.2M 0.94%
46,680
-980
-2% -$196K
GOOGL icon
17
Alphabet (Google) Class A
GOOGL
$3.91T
$12M 0.93%
100,189
+307
+0.3% +$35.3K
DNLI icon
18
Denali Therapeutics
DNLI
$3.65B
$11.2M 0.86%
378,267
+87,937
+30% +$2.47M
GOOG icon
19
Alphabet (Google) Class C
GOOG
$3.9T
$10.8M 0.84%
89,540
-1,172
-1% -$136K
VUG icon
20
Vanguard Growth ETF
VUG
$216B
$9.95M 0.77%
211,074
+240
+0.1% +$10.4K
CINF icon
21
Cincinnati Financial
CINF
$28.1B
$9.72M 0.75%
99,828
-73
-0.1% -$7.54K
IWB icon
22
iShares Russell 1000 ETF
IWB
$47.7B
$9.6M 0.74%
39,400
BRK.B icon
23
Berkshire Hathaway Class B
BRK.B
$1.06T
$8.33M 0.64%
24,427
+324
+1% +$106K
SMAR
24
DELISTED
Smartsheet Inc.
SMAR
$7.34M 0.57%
191,833
META icon
25
Meta Platforms (Facebook)
META
$1.52T
$7.28M 0.56%
25,375
+1,880
+8% +$464K

Similar funds

Clarius Group LLC's Q2 2023 Portfolio in Review

As of Q2 2023, Clarius Group LLC held 529 positions worth $1.29B, up 9.9% from $1.18B the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Clarius Group LLC's Q2 2023 filing shows 19 new, 248 increased, 179 reduced and 39 closed positions. Its largest new stake was Euclidean Fundamental Value ETF: 507,159 shares worth $14M. The largest sale was PACCAR, an estimated $4.8M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Clarius Group LLC's largest Q2 2023 buy was Euclidean Fundamental Value ETF: 507,159 shares worth $14M.
  • Clarius Group LLC added most to Denali Therapeutics in Q2 2023, an estimated $2.47M increase.
  • Clarius Group LLC's biggest Q2 2023 reduction was PACCAR, cutting an estimated $4.8M.
  • Clarius Group LLC fully exited iShares National Muni Bond ETF in Q2 2023, selling an estimated $904K.
  • Clarius Group LLC's ten largest holdings make up 53% of its $1.29B portfolio in Q2 2023.
  • Clarius Group LLC opened 19 new positions and closed 39 in Q2 2023.
  • Clarius Group LLC's portfolio value rose 9.9% quarter-over-quarter to $1.29B.

Based on Clarius Group LLC's 13F filing for Q2 2023, filed 10 Aug 2023.